Efficacy and Safety of Anti-CD38 Monoclonal Antibodies in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Randomized Clinical TrialsFrancisco Cézar Aquino de Moraes, Rommel Mário Rodríguez Burbano|Journal of Personalized Medicine|2024Cited by 2